CN¥24.02
2.69%
Shanghai, Sep 30, 03:00 pm CST.
ISIN
CNE100001M79
Symbol
600196

Shanghai Fosun Pharmaceuti-h Target price 2026 - Analyst rating & recommendation

Shanghai Fosun Pharmaceuti-h Classifications & Recommendation

Buy
70%
Hold
30%

Shanghai Fosun Pharmaceuti-h Price Target

Target Price CN¥33.51
Price CN¥24.02
Potential
Number of Estimates 5
5 Analysts have issued a price target Shanghai Fosun Pharmaceuti-h 2027 . The average Shanghai Fosun Pharmaceuti-h target price is CN¥33.51. This is higher than the current stock price. The highest price target is
CN¥35.39 47.31%
register free of charge
, the lowest is .
A rating was issued by 10 analysts: 7 Analysts recommend Shanghai Fosun Pharmaceuti-h to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Shanghai Fosun Pharmaceuti-h stock has an average upside potential 2027 of . Most analysts recommend the Shanghai Fosun Pharmaceuti-h stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion CN¥ 41.66 43.26
1.45% 3.83%
EBITDA Margin 11.01% 14.04%
1.78% 27.49%
Net Margin 8.09% 9.00%
19.95% 11.24%

7 Analysts have issued a sales forecast Shanghai Fosun Pharmaceuti-h 2026 . The average Shanghai Fosun Pharmaceuti-h sales estimate is

CN¥43.3b
unlock
. This is
1.57% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
CN¥47.9b 12.49%
unlock
, the lowest is
CN¥40.7b 4.46%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 CN¥41.7b 1.45%
2026
CN¥43.3b 3.83%
unlock
2027
CN¥44.6b 3.15%
unlock
2028
CN¥47.7b 6.83%
unlock

7 Shanghai Fosun Pharmaceuti-h Analysts have issued a net profit forecast 2026. The average Shanghai Fosun Pharmaceuti-h net profit estimate is

CN¥3.9b
unlock
. This is
14.84% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
CN¥4.2b 23.24%
unlock
, the lowest is
CN¥3.5b 4.22%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 CN¥3.4b 21.69%
2026
CN¥3.9b 15.51%
unlock
2027
CN¥4.4b 12.63%
unlock
2028
CN¥4.9b 11.98%
unlock

Net Margin

2025 8.09% 19.95%
2026
9.00% 11.24%
unlock
2027
9.83% 9.22%
unlock
2028
10.30% 4.78%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share CN¥ 1.27 1.46
22.12% 14.96%
P/E 16.48
EV/Sales 1.94

7 Analysts have issued a Shanghai Fosun Pharmaceuti-h forecast for earnings per share. The average Shanghai Fosun Pharmaceuti-h EPS is

CN¥1.46
unlock
. This is
13.18% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
CN¥1.56 20.93%
unlock
, the lowest is
CN¥1.32 2.33%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 CN¥1.27 22.12%
2026
CN¥1.46 14.96%
unlock
2027
CN¥1.64 12.33%
unlock
2028
CN¥1.84 12.20%
unlock

P/E ratio

Current 18.62 22.36%
2026
16.48 11.49%
unlock
2027
14.63 11.23%
unlock
2028
13.06 10.73%
unlock

Based on analysts' sales estimates for 2026, the Shanghai Fosun Pharmaceuti-h stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.97 18.60%
2026
1.94 1.55%
unlock
2027
1.88 3.05%
unlock
2028
1.76 6.39%
unlock

P/S ratio

Current 1.40 24.29%
2026
1.38 1.55%
unlock
2027
1.34 3.05%
unlock
2028
1.25 6.39%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today